Thymidylate synthase dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients
Thymidylate synthase dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients
复制标题
DOI:
10.1097/01.fpc.0000230410.07899.bc
复制
发表时间:
2006-11-01
影响因子:
2.6
通讯作者:
Danesi, Romano
中科院分区:
文献类型:
--
作者:
Amatori, Federica;Di Paolo, Antonello;Danesi, Romano
Objective To compare thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and thymidine phosphorylase (TP) gene polymorphism and expression in colorectal cancer (CRC), and normal mucosa in chemotherapy-naive patients.Methods TS, DPD and TP mRNA expression was analysed by real-time reverse-transcription polymerase chain reaction in primary CRC and adjacent normal tissues from 53 patients with glyceraidehyde-3-phosphate dehydrogenase as housekeeping gene. TS promoter (TSER and C/G SNP) and DPD IVS14 + 1G > A genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism assays. Moreover, the correlation between TS, DPD and TP expression and cytotoxicity of 5-fluorouracil was evaluated in Colo 320, HT-29, CaCo-2 and SW620 human CRC cell lines.Results TP and DPD mRNA expression was significantly different in tumour and normal tissue (751 +/- 13.50 vs. 1.10 +/- 0.57, P < 0.05 and 0.60 +/- 0.63 vs. 1.17 +/- 0.55, P